Word

EVLABIO

Status

Registered

Status Code

700

Status Date

Tuesday, September 10, 2024

Serial Number

79351651

Registration Number

7497680

Registration Date

Tuesday, September 10, 2024

Mark Type

4

Filing Date

Monday, May 23, 2022

Published for Opposition

Tuesday, June 18, 2024

Trademark Owner History

EvlaBio AG - Original Registrant
Dr. Robert Kirmeier - Owner At Publication

Classifications

9 Data processing equipment, computer hardware; downloadable and recorded computer software for providing, analyzing and generating reports in the field of healthcare, pharmaceutical and biomedical research; downloadable and recorded computer software for data processing in the field of healthcare, pharmaceutical and biomedical research; electronic data processing apparatus, downloadable and recorded software, computer programs and hardware for the scientific analysis and electronic storage of artificial intelligence data in the field of healthcare, pharmaceutical and biomedical research; all of the aforementioned goods in the field of healthcare, pharmaceutical and biomedical research; downloadable and recorded software for scientific analysis of clinical trial data in the fields of public health, healthcare, pharmaceutical and biomedical research and downloadable and recorded software for scientific analysis of data from clinical trials and data derived from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; downloadable computer software featuring computer databases of pharmaceuticals and medical information; downloadable computer software for management of medical practices and conducting medical research; downloadable computer software for measuring, monitoring, processing and tracking health and medical information; downloadable computer search engine software for obtaining and providing updated scientific, medicinal, pharmaceutical and clinical information; computer hardware and downloadable and recorded software for use with medicinal patient monitoring equipment and for receiving, processing, transmitting and displaying data in the field of healthcare; downloadable and recorded artificial intelligence software for tracking data for use in medical and scientific healthcare research

5 Pharmaceutical preparations for human use, namely, preparations for the prevention and treatment of cancer and kidney diseases or disorders, preparations for the prevention and treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, preparations for the prevention and treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, cognitive disorders, diabetes; biologic preparations for medical and therapeutic purposes, namely, preparations for the prevention and treatment of cancer and kidney diseases or disorders, preparations for the prevention and treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, preparations for the prevention and treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, cognitive disorders, diabetes

36 Financial analysis of investments in pharmaceutical and biomedical research and development and clinical trials and post-authorization research; providing financial services with respect to securities and other financial instruments and products, namely, trading of and investments in securities and financial instruments and products for others; financial evaluation, tracking, analysis, forecasting, consultancy and research services relating to securities and other financial instruments; financial research related to financial instruments; clearing and reconciling financial transactions via blockchain technology; electronic funds transfer provided via blockchain technology

35 Business data analysis and statistical analysis for business purposes relating to healthcare data, biomedical and pharmaceutical research and clinical trial data and data from post-authorization research for marketing of medicines and commercial post-launching of medicines; business analysis and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; compilation of business data, analysis of business data and business management analysis in the field of pharmaceutical and biomedical research and development, clinical trials, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare; compilation of business data, analysis of business data and business management analysis for medical, public health and healthcare purposes; business research, business market research and statistical analysis of business data in the fields of public health, health care, biomedicine and pharmaceuticals, clinical trials and post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing marketing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare; business risk management and business risk assessment services in the fields of pharmaceuticals and biomedicine; business services provided to the healthcare industry, namely, the collection, business reporting, and analysis of healthcare data for business purposes

42 Product research in the field of medical, pharmaceutical and biologic therapeutic products; medical research, pharmaceutical research and pharmaceutical drug development services; providing scientific research information in the field of medical, pharmaceuticals, biomedicine, clinical trials and post-authorization research and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software containing databases of pharmaceutical products, medical information, clinical trial data and data derived from post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software for management of medical practices and conducting medical research; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medicinal information and for controlling and managing data and information related to healthcare services and patient medicinal information; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; providing temporary use of non-downloadable software for financial analytics via blockchain technology; providing temporary use of non-downloadable artificial intelligence computer programs on data networks for tracking data for use in medical and scientific research; software as a service (SaaS) featuring software platforms for database management in healthcare

Trademark Events

Mar 11, 2023

Assigned To Examiner

Oct 6, 2022

Sn Assigned For Sect 66a Appl From Ib

Oct 7, 2022

New Application Office Supplied Data Entered

Oct 11, 2022

Application Filing Receipt Mailed

Mar 11, 2023

Non-Final Action Written

Mar 12, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Apr 30, 2023

Refusal Processed By Mpu

Apr 30, 2023

Non-Final Action Mailed - Refusal Sent To Ib

May 24, 2023

Refusal Processed By Ib

Oct 30, 2023

Teas Response To Office Action Received

Oct 30, 2023

Correspondence Received In Law Office

Oct 30, 2023

Teas/Email Correspondence Entered

Dec 4, 2023

Final Refusal Written

Dec 4, 2023

Final Refusal E-Mailed

Dec 4, 2023

Notification Of Final Refusal Emailed

Mar 6, 2024

Notification Of Possible Opposition Sent To Ib

Mar 6, 2024

Notification Of Possible Opposition Created, To Be Sent To Ib

May 13, 2024

Approved For Pub - Principal Register

May 13, 2024

Teas/Email Correspondence Entered

May 13, 2024

Correspondence Received In Law Office

May 13, 2024

Teas Request For Reconsideration Received

May 29, 2024

Notification Of Notice Of Publication E-Mailed

Jun 11, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jun 11, 2024

Notification Of Possible Opposition Sent To Ib

Mar 26, 2024

Notification Of Possible Opposition - Processed By Ib

Jun 18, 2024

Published For Opposition

Jun 18, 2024

Official Gazette Publication Confirmation E-Mailed

Aug 1, 2024

On Hold - Electronic Record Review Required

Sep 10, 2024

Registered-Principal Register

Sep 10, 2024

Notice Of Registration Confirmation Emailed

Jul 14, 2024

Notification Processed By Ib

Jul 6, 2024

Change Of Owner Received From Ib